Document Detail


A Highly Soluble MMP-9 Inhibitor for Potential Treatment of Dry Eye Syndrome.
MedLine Citation:
PMID:  22520332     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Dry eye syndrome (DES) or keratoconjunctivitis sicca is an eye disease caused by the chronic lack of lubrication and moisture of the eye. The pathogenesis of DES involves the over-expression and over-activity of corneal Matrix Metalloproteinase 9 (MMP-9). We propose herein a new, non-symptomatic, approach for the treatment of DES based on the inhibition of MMP-9 by a new highly soluble molecule, designed as PES_103 that has been shown to inhibit MMP-9 both in vitro and in vivo. The efficacy of PES_103 in vivo and the potential benefits of this treatment in restoring tear production were studied in this work by using an animal model of reduced lacrimation. PES_103 did not show any significant corneal toxicity.
Authors:
Mattia Mori; Emanuele De Lorenzo; Eugenio Torre; Marco Fragai; Cristina Nativi; Claudio Luchinat; Annarosa Arcangeli
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-4-23
Journal Detail:
Title:  Basic & clinical pharmacology & toxicology     Volume:  -     ISSN:  1742-7843     ISO Abbreviation:  -     Publication Date:  2012 Apr 
Date Detail:
Created Date:  2012-4-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101208422     Medline TA:  Basic Clin Pharmacol Toxicol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2012 The Authors Basic & Clinical Pharmacology & Toxicology © 2012 Nordic Pharmacological Society.
Affiliation:
ProtEra Srl, Scientific Campus of the University of Florence, Sesto Fiorentino (Florence), Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Association analysis between HOXD9 genes and the development of developmental dysplasia of the hip i...
Next Document:  Transcriptional activation of Brassica napus?-ketoacyl-ACP synthase II with an engineered zinc finge...